Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,261 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06398795Recruiting
Dual-port thyroid surgery through the armpit
This trial tests a new type of minimally invasive thyroid surgery that uses two small openings under your collarbone to remove thyroid growths. It may be a good option if you want less visible scarring from your thyroid operation.
Wenzhou, ZhejiangAges 18–90 - NCT06020755RecruitingPhase 2
Toripalimab plus actinomycin-D for GTN with FIGO score 7
This trial tests a combination of two drugs — toripalimab (an immunotherapy) and actinomycin-D (chemotherapy) — as the first treatment for a specific type of pregnancy-related tumor (GTN) with a FIGO score of 7. The goal is to see if this combination works better than standard treatment.
Beijing, Beijing MunicipalityAges 18–60 - NCT06385834Recruiting
Morning vs Evening Exercise After Heart Attack
This study compares the effects of doing aerobic exercise in the morning versus the evening for people who recently had a heart attack. It aims to see if timing of exercise can help the heart recover and function better.
ShanghaiAges 17–75 - NCT06588231Recruiting
Personalized exercise for older adults with heart disease
This study tests whether a personalized exercise program can help older people (60–75) with stable coronary heart disease improve their heart health. You would work with healthcare professionals to get an exercise plan tailored to your condition.
Nanjing, JiangsuAges 60–75 - NCT06673290RecruitingPhase 2/Phase 3
Testing different doses of sirolimus for cystic lymphatic malformations
This trial tests different doses of sirolimus (a medication that slows cell growth) to find the best dose for treating cystic lymphatic malformations in children. It may help shrink the abnormal fluid-filled growths and improve symptoms.
Chengdu, SichuanAges 1–18 - NCT06719791RecruitingEarly Phase 1
Sirolimus for hard-to-treat focal epilepsy
This trial tests if the drug sirolimus can help people with focal seizures (starting in one part of the brain) that don't improve with at least two other medications. It aims to reduce seizure frequency in adults aged 18 to 60.
BeijingAges 18–60 - NCT06754267RecruitingPhase 2
Studying a new drug combo for Ph+ B-ALL
This trial tests a combination of three drugs (venetoclax, olverembatinib, and prednisone) for adults newly diagnosed with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia (Ph+ B-ALL). The goal is to see if this combination is safe and effective.
Hangzhou, ZhejiangAges 18 years+ - NCT06752304Recruiting
A long-term study of severe eating disorders
This study follows people with long-term eating disorders to understand how the condition changes over time. It may help researchers improve care for those who have struggled for years.
UppsalaAges 14 years+ - NCT06749639RecruitingEarly Phase 1
Gene therapy trial for RDH12-related eye disease
This trial tests an injection called PUMCH-E101 for people with vision loss caused by changes in the RDH12 gene. The goal is to see if it is safe and if it can help improve vision.
Beijing, Beijing MunicipalityAges 8–45 - NCT06752798RecruitingPhase 2
Trilaciclib to protect bone marrow after head and neck cancer surgery and chemoradiation
This trial tests if trilaciclib can protect bone marrow during chemoradiation after surgery for advanced head and neck cancer. It is for people with specific risk factors found after surgery.
Changsha, HunanAges 18–70 - NCT06753981Recruiting
Triple drug therapy for new PAH patients
This trial tests whether a combination of three medications works well and is safe for people newly diagnosed with pulmonary arterial hypertension (PAH) that is not low-risk. It aims to see if starting with triple therapy early can improve outcomes.
Jinan, ShandongAges 18–80 - NCT06754358RecruitingPhase 1
Comparing two laser systems for cataract surgery
This study compares two types of femtosecond lasers used during cataract surgery. It is for people of Chinese Han ethnicity who are 40 or older and have age-related cataracts.
Hangzhou, ZhejiangAges 40 years+ - NCT06754488Recruiting
New Surgical Technique for Bladder Control After Prostate Removal
This trial tests a new surgical technique during laparoscopic prostate removal to help patients regain bladder control (urinary continence) faster. It's for men with early-stage prostate cancer who are good candidates for surgery.
Suzhou, JiangsuAges Up to 79 years - NCT05151926Recruiting
Rehab trial after tibia bone fracture surgery
This trial studies rehabilitation after a tibia (shinbone) shaft fracture that is fixed with a metal nail. You may be asked to complete questionnaires and to take part in a rehab plan that aims to improve recovery after injury.
Jyväskylä, Central FinlandAges 18–65 - NCT06654596Recruiting
Telitacicept for IgA nephropathy
This study tests a new medicine called telitacicept for people with IgA nephropathy, a kidney disease that causes protein in the urine. The goal is to see if it safely reduces kidney damage.
ShanghaiAges 18–70 - NCT06755866Recruiting
Predicting chemo-radiation response with improved MRI for esophageal cancer
This trial uses a special MRI technique to see if it can predict how well esophageal cancer responds to chemo-radiotherapy before surgery. It may help doctors choose the best treatment plan for you.
Kunming, YunnanAges 18–80 - NCT06756217Recruiting
PET scan to check early response to immunotherapy before lung cancer surgery
This trial tests a special PET scan (68Ga-grazytracer) to see if it can predict early whether immunotherapy is working in people with lung cancer that can be surgically removed. If successful, this scan could help doctors tailor treatment sooner.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06755138Recruiting
Scoliosis, pain, and quality of life in Duchenne muscular dystrophy
This study looks at how scoliosis (curved spine) and back pain affect daily life in people with Duchenne muscular dystrophy. Researchers will measure muscle strength and compensation patterns to understand these links.
SeoulAges 11–30 - NCT06755762Recruiting
3D blood test for advanced head and neck cancer
This study uses a special 3D culture method to grow and analyze tumor cells from the blood of people with advanced head and neck cancer. It also includes healthy volunteers for comparison, to help researchers understand how these cells behave and improve future detection.
TaoyuanAges 18–80 - NCT06756022Recruiting
Dolasetron to prevent nausea from chemo in kids with leukemia
This trial tests if a medicine called dolasetron can prevent chemotherapy-related nausea and vomiting in children with acute lymphoblastic leukemia (ALL). It may help kids feel better during their first round of treatment.
Hefei, AnhuiAges 2–17 - NCT06755775Recruiting
PET scan to predict immunotherapy success in DLBCL
This trial uses a special PET scan to see if a protein called Granzyme B can predict how well immunotherapy will work for people with DLBCL. It aims to help doctors know earlier if treatment is effective.
ShanghaiAges 18 years+ - NCT07517796RecruitingPhase 4
IV Papaverine to Help Induce Labor in Pregnancies with Broken Water
This study tests whether an IV medication called papaverine can help induce labor in pregnant people at term (37+ weeks) whose water has broken but labor hasn't started yet. The goal is to see if this medication makes labor start naturally and reduces the need for cesarean delivery.
Nahariya, IsraelAges 18–45 - NCT07520734Recruiting
Laser Treatment for Internal Hemorrhoids: Treatment Outcomes
This study tracks how well laser treatment works for people with symptomatic internal hemorrhoids (swollen blood vessels in the lower rectum that cause bleeding, itching, or pain). You would undergo the laser procedure and be followed to see how your symptoms improve.
Sanliurfa, ŞanlıurfaAges 18 years+ - NCT07522203Recruiting
Heart Function Recovery After Balloon Angioplasty for Lung Blood Clots
This study looks at how a minimally invasive procedure called balloon pulmonary angioplasty (BPA) helps patients with chronic blood clots in the lungs improve their heart function and overall recovery. Researchers will measure blood flow patterns in your arteries before and after the procedure to understand how well your heart recovers.
IstanbulAges 18–85
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,261 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.